First-in-human study of 4SC-205 (AEGIS), a novel oral inhibitor of Eg5 kinesin spindle protein.
Klaus B. Mross
No relevant relationships to disclose
Dirk Scharr
No relevant relationships to disclose
Heike Richly
No relevant relationships to disclose
Annette Frost
No relevant relationships to disclose
Sebastian Bauer
No relevant relationships to disclose
Babett Krauss
Employment or Leadership Position - 4SC
Stock Ownership - 4SC
Rolf Krauss
Employment or Leadership Position - 4SC
Stock Ownership - 4SC
Anna Mais
No relevant relationships to disclose
Bernhard Hauns
Employment or Leadership Position - 4SC
Bernd Hentsch
Employment or Leadership Position - 4SC
Stock Ownership - 4SC
Roland Baumgartner
Employment or Leadership Position - 4SC
Stock Ownership - 4SC
Max E. Scheulen
Consultant or Advisory Role - 4SC